Find Your Fit: 4 New Additions to the Belkin SoundForm Audio Collection Announced at IFA 2024
5.9.2024 10:00:00 CEST | Business Wire | Press release
SoundForm offers more options for premium features at accessible price points Belkin International at Exhibit Hall 3.2, stand #210
Belkin, a leading consumer electronics brand for over 40 years, today announced 4 new products across its SoundForm audio category, underscoring Belkin innovation, quality and its commitment to building products more responsibly. Belkin International can be found on the IFA show floor, Exhibit Hall 3.2, stand #210.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905446437/en/
Belkin announces new SoundForm portfolio at IFA 2024 (Photo: Business Wire)
Designed in its in-house labs at Belkin Global Headquarters in California, every SoundForm product undergoes 150 meticulous quality tests, ensuring perfection before it reaches consumer’s ears. Design, sound quality, comfort, voice-calling performance, enhanced features and value are all considered with each new addition to the SoundForm portfolio.
Belkin Signature Sound is integrated throughout the SoundForm range. Developed by Belkin sound engineers, it allows the wearer to listen to music exactly the way the artist intended. Deep bass is balanced, vocals are crystal-clear, and treble is crisp. To do this, Belkin sound engineers test headphone and earphone frequency response and distortion, passive noise isolation, Environmental Noise Cancellation (ENC), Active Noise Cancellation (ANC) performance, and Sound Pressure Level (SPL) to ensure proper 98db output for ‘adult’ products and 85db ‘safe sound’ for ‘kids’ products—and more. All new SoundForm products feature ENC for voice isolating clear call quality as standard.
Consumers will find a product in the SoundForm collection to suit their needs–all without breaking the bank.
SoundForm Rhythm
The SoundForm Rhythm earbuds pack a punch while taking up minimal space. They were designed for consumers looking for a casual pair of earbuds for entertainment, work/study purposes, or daily use.
Features:
- Design: True wireless, stem-shaped
- Sound: 6mm drivers
- Battery life: 8 hours with an additional 20 hours of battery life in charging case; 10 minutes of charge gets 90 minutes of playtime
- Connection: Bluetooth 5.3 and Multipoint
- Included in package: USB-C fast charging compatible case
- Built with recycled plastics and packaged in 100% plastic-free packaging
- 2-year warranty
Price: $34.99 / £24.99 / €29.99
Availability: SoundForm Rhythm is available now on belkin.com and select retailers worldwide
SoundForm ClearFit
Get a (good) grip with the SoundForm ClearFit. When it’s time to move, ClearFit is a go-to. Perfect for sports, outdoor activities and workouts, these earbuds stay comfortably secured around the outer ear for great sound while allowing the user to stay aware of their surroundings.
Features:
- Design: Open-ear, secure, comfortable and IPx5 sweat resistant
- Sound: 14.2mm drivers
- Battery life: 8 hours with an additional 18 hours of battery life in charging case; 10 minutes of charge gets 90 minutes of playtime
- Connection: Bluetooth 5.3 and Multipoint
- Included in package: USB-C fast charging compatible case
- Built with recycled plastics and packaged in 100% plastic-free packaging
- 2-year warranty
Price: $59.99 / £39.99 / €49.99
Availability: SoundForm ClearFit is available now on belkin.com/de and belkin.com/uk and select retailers worldwide
SoundForm Isolate
The SoundForm Isolate is the first over-ear headphone with ANC by Belkin. Made for the modern and stylish individual, Isolate provides quality ANC at a reasonable price point. In addition to ANC, Isolate also has a built-in “Relaxation” track that plays on a loop for moments where you need to further tune out external noise. They come with a long battery life of 60 hours, 3 settings (Standard Listening, Active Noise Cancellation, Hear Thru Mode) and Bluetooth multipoint – all in a sleek and portable design.
Features:
- Design: Over-ear, foldable, extendable and comfortable with 5 mics and intuitive touch controls to easily manage sound with a tap
- Sound: 40mm drivers
- Battery life: 60 hours of battery life (40 hours with ANC on)
- Connection: Bluetooth 5.4 and Multipoint
- Included in package: USB-C charging and audio cable; 3.5mm audio cable for users that prefer wired connection
- Built with recycled plastics and packaged in 100% plastic-free packaging
- 2-year warranty
Price: $59.99 / £49.99 / €59.99
Availability: SoundForm Isolate will be available from Autumn 2024
SoundForm Surround
The SoundForm Surround over-ear headphones are perfect for when you need to chat on the go. ENC ensures clear calls with background noise kept to a whisper. Its foldable, extendable, and comfortable over-ear design and intuitive touch controls make SoundForm Surround an everyday accessory.
Features:
- Design: Over-ear, foldable, extendable and comfortable with intuitive touch controls to easily manage sound with a tap
- Sound: 40mm drivers
- Battery life: 60 hours
- Connection: Bluetooth 5.4 and Multipoint
- Included in package: USB-C charging and audio cable; 3.5mm audio cable for users that prefer wired connection
- Built with recycled plastics and packaged in 100% plastic-free packaging
- 2-year warranty
Price: $39.99 / £29.99 / €39.99
Availability: SoundForm Surround will be available from Autumn 2024
All new products are made with post-consumer recycled (PCR) plastics in line with the company’s commitment to find more responsible ways to build products. They will be on display at IFA 2024.
Media kit is available for download HERE.
About Belkin
Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From our humble beginnings in a Southern California garage in 1983, Belkin has become a diverse, global technology company. We remain forever inspired by the planet we live on, and the connection between people and technology.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905446437/en/
Contacts
For Media Inquiries:
For Media Inquiries:
Jen Wei
VP of Global Communications and Corporate Development
Comms@belkin.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom